Article
Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
Cancer chemotherapy and pharmacology - 1 May 2013
Zhao Wan, Hu Lingmin, Xu Jiali, Shen Hongbing, Hu Zhibin, Ma Hongxia, Shu Yongqian, Shao Yongfeng, Yin Yongmei
Abstract excerpt
PURPOSE: Platinum-based chemotherapy is the most common treatment for patients with advanced non-small cell lung cancer (NSCLC). Genetic polymorphisms in the base excision repair (BER) pathway are suspected to influence the response of patients to this type of therapy. In this study, we investigated whether nonsynonymous single nucleotide polymorphisms (SNPs) in the BER pathway were associated with the response,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
